172 related articles for article (PubMed ID: 7491691)
1. Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.
Gautreau C; Kojima T; Woimant G; Cardoso J; Devillier P; Houssin D
Transplantation; 1995 Nov; 60(9):903-7. PubMed ID: 7491691
[TBL] [Abstract][Full Text] [Related]
2. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin.
Kojima T; Hayashi S; Yokoyama I; Takagi H
Transplantation; 1996 Sep; 62(5):559-62. PubMed ID: 8830815
[TBL] [Abstract][Full Text] [Related]
3. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
[No Abstract] [Full Text] [Related]
5. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
Latremouille C; Haeffner-Cavaillon N; Goussef N; Mandet C; Hinglais N; Bruneval P; Bariety J; Carpentier A; Glotz D
Transplant Proc; 1994 Jun; 26(3):1285. PubMed ID: 8029910
[No Abstract] [Full Text] [Related]
6. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
Candinas D; Bach FH; Hancock WW
Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
[No Abstract] [Full Text] [Related]
7. Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
Urbani L; Cardoso J; Soubrane O; Houssin D; Gautreau C
Transplant Proc; 2000 Dec; 32(8):2707-9. PubMed ID: 11134770
[No Abstract] [Full Text] [Related]
8. [Attempt at preventing hyperacute xenogenic rejection by isotopic suppression of IgM in the recipient].
Pitre J; Kahan A; Fontaliran P; Houssin D; Weill B
Ann Chir; 1996; 50(7):524-31. PubMed ID: 9035421
[TBL] [Abstract][Full Text] [Related]
9. Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
Genevaz D; Latremouille C; Goussev N; Carpentier A; Glotz D
Transplant Proc; 1996 Apr; 28(2):853-4. PubMed ID: 8623433
[No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulins for therapeutic use contain anti-idiotypes against xenophile antibodies and prolong discordant graft survival.
Schussler O; Genevaz D; Latremouille C; Goussev N; Kaveri S; Glotz D
Clin Immunol Immunopathol; 1998 Feb; 86(2):183-91. PubMed ID: 9473381
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
Magee JC; Collins BH; Harland RC; Bollinger RR; Frank MM; Platt JL
Transplant Proc; 1995 Feb; 27(1):271. PubMed ID: 7878999
[No Abstract] [Full Text] [Related]
12. Intravenous immunoglobulin delays xenogeneic hyperacute rejection in a model of pig liver perfused with human blood.
Gautreau C; Grosse H; Fabre M; Soubrane O; Woimant G; Lobontiu A; Kojima T; Cherruau B; Devillier P; Houssin D; Cardoso J
Transplant Proc; 1996 Apr; 28(2):764. PubMed ID: 8623390
[No Abstract] [Full Text] [Related]
13. Fetal inoculation with donor cells in cardiac xenotransplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
[TBL] [Abstract][Full Text] [Related]
14. Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity.
Latremouille C; Genevaz D; Hu MC; Schussler O; Goussef N; Mandet C; Bruneval P; Haeffner-Cavaillon N; Carpentier A; Glotz D
Clin Exp Immunol; 1997 Oct; 110(1):122-6. PubMed ID: 9353158
[TBL] [Abstract][Full Text] [Related]
15. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
16. Discordant heart xenografts in the rat. Additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection.
Van de Stadt J; Vendeville B; Weill B; Crougneau S; Michel A; Filipponi F; Icard P; Renoux M; Louvel A; Houssin D
Transplantation; 1988 Mar; 45(3):514-8. PubMed ID: 3279572
[TBL] [Abstract][Full Text] [Related]
17. Effects of complement suppression on xenograft survival in hyperacute rejection.
Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
[TBL] [Abstract][Full Text] [Related]
18. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
[TBL] [Abstract][Full Text] [Related]
19. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
[TBL] [Abstract][Full Text] [Related]
20. Effect of anticomplement reagents, K-76 COOH and FUT175, on discordant xenograft survival.
Miyagawa S; Shirakura R; Matsumiya G; Kitagawa S; Fukushima N; Nakata S; Nakano S; Kitamura H; Matsumoto M; Seya T
Transplant Proc; 1992 Apr; 24(2):483-4. PubMed ID: 1566397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
